U.S., Dec. 10 -- An application to own the trademark for 'RETRIG' has been filed on Jun. 20, 2025.
Owner(s):
SFJ Pharma X, Inc.; 4682 Chabot Drive, #10034, , CALIFORNIA
Goods and/or Services:
For: Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-12-09&serialNumber=99245347
Disclaimer: Curated by HT Syndication....